Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000874361 | SCV001016526 | likely benign | Hypercholesterolemia, familial, 4 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002363292 | SCV002659656 | likely benign | Cardiovascular phenotype | 2019-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001275176 | SCV001460021 | likely benign | Familial hypercholesterolemia | 2020-04-30 | no assertion criteria provided | clinical testing |